Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10353
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRahimbayeva, Gulnora-
dc.date.accessioned2024-01-16T13:17:53Z-
dc.date.available2024-01-16T13:17:53Z-
dc.date.issued2023-08-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/10353-
dc.description.abstract. Cerebral amyloid angiopathy (CAA) is the generally accepted term used to define amyloid deposits in the walls of leptomeningeal and cortical arteries of medium and small diameter, arterioles, less often capillaries and veins. Cerebral amyloid angiopathy is an important cause of cerebral haemorrhage, although it can also lead to ischemic infarction and dementia. Patients with CAA may have a wide clinical spectrum, including cognitive decline, lobar intracranial haem orrhage, and transient focal neurological episodes (recurrent, stereotyped, transient episodes of smoothly spreading pares thesia’s, numbness, or weakness, usually lasting seconds to minutes, usually resolving within a similar peen_US
dc.language.isoenen_US
dc.publisherJournal of education and scientific medicineen_US
dc.subjectCerebral amyloid angiopathy, Alzheimer's disease, intracranial haemorrhage, MRIen_US
dc.titleCerebral Manifestations of Amyloidosis: questions of early diagnosis and therapyen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
Рахимбаева ГС + 1 автор хорижий макола август.pdfCerebral Manifestations of Amyloidosis: questions of early diagnosis and therapy1.23 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.